Patents by Inventor Eric M. Friets
Eric M. Friets has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20200206441Abstract: A nasal delivery device can include a nasal prong and an activation member. The nasal prong can have an opening at a top and bottom portion of the prong to allow for the passage of an aerosolized treatment agent through the nasal prong. The activation member can be positioned on the nasal delivery device at a location that is spaced apart from the subject's oral cavity when the nasal prong is received into the nostril of the subject. The activation member can detect a desired exhalation state of the subject and upon detection of the desired exhalation state, the activation member activates the delivery of the aerosolized treatment agent.Type: ApplicationFiled: February 21, 2020Publication date: July 2, 2020Applicants: The United States of America, as represented by the Secretary, Department of Health & Human Services, Creare LLCInventors: Mark J. Papania, James J. Barry, Mark C. Bagley, James Norris, Darin A. Knaus, Eric M. Friets
-
Patent number: 10596334Abstract: A nasal delivery device can include a nasal prong and an activation member. The nasal prong can have an opening at a top and bottom portion of the prong to allow for the passage of an aerosolized treatment agent through the nasal prong. The activation member can be positioned on the nasal delivery device at a location that is spaced apart from the subject's oral cavity when the nasal prong is received into the nostril of the subject. The activation member can detect a desired exhalation state of the subject and upon detection of the desired exhalation state, the activation member activates the delivery of the aerosolized treatment agent.Type: GrantFiled: April 3, 2014Date of Patent: March 24, 2020Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, Creare, IncorporatedInventors: Mark J. Papania, James J. Barry, Mark C. Bagley, James Norris, Darin A. Knaus, Eric M. Friets
-
Publication number: 20190009040Abstract: A nasal delivery device can include air-receiving section that has a first passageway therethrough to allow air to pass through the air-receiving section, a powder-reservoir receiving section sized to receive a powder reservoir, and a powder-delivery section that has a second passageway therethrough to allow aerosolized powder from the powder reservoir to pass through the powder-delivery section. The first passageway can have a first end and a second end, with the first end being further from the powder-reservoir receiving section and the second end being at or near the powder-reservoir receiving area. The second end of the air-receiving section can include a flattened region so that air exiting the air-receiving section has a generally flattened profile.Type: ApplicationFiled: September 7, 2018Publication date: January 10, 2019Applicants: The United States of America, as represented by the Secretary, Department of Health and Human Serv, Creare LLCInventors: Mark J. Papania, James J. Barry, Mark C. Bagley, Darin A. Knaus, Eric M. Friets, Edward Moynihan
-
Patent number: 10099024Abstract: A nasal delivery device can include air-receiving section that has a first passageway therethrough to allow air to pass through the air-receiving section, a powder-reservoir receiving section sized to receive a powder reservoir, and a powder-delivery section that has a second passageway therethrough to allow aerosolized powder from the powder reservoir to pass through the powder-delivery section. The first passageway can have a first end and a second end, with the first end being further from the powder-reservoir receiving section and the second end being at or near the powder-reservoir receiving area. The second end of the air-receiving section can include a flattened region so that air exiting the air-receiving section has a generally flattened profile.Type: GrantFiled: June 24, 2013Date of Patent: October 16, 2018Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, Creare, IncorporatedInventors: Mark J. Papania, James J. Barry, Mark C. Bagley, Darin A. Knaus, Eric M. Friets, Edward Moynihan
-
Publication number: 20170020383Abstract: A nasal delivery device can include a nasal prong and an activation member. The nasal prong can comprises an opening at a top and bottom portion of the prong to allow for the passage of an aerosolized treatment agent through the nasal prong. The activation member can be positioned on the nasal delivery device at a location that is spaced apart from the subject's oral cavity when the nasal prong is received into the nostril of the subject. The activation member can be configured to detect a desired exhalation state of the subject and upon detection of the desired exhalation state, the activation member activates the delivery of the aerosolized treatment agent.Type: ApplicationFiled: October 7, 2016Publication date: January 26, 2017Applicants: The USA, as represented by the Secretary, Department of Health and Human Services, Creare LLCInventors: Mark J. Papania, James J. Barry, Mark C. Bagley, Eric M. Friets, Darin A. Knaus
-
Patent number: 9492068Abstract: A nasal delivery device can include a nasal prong and an activation member. The nasal prong can comprises an opening at a top and bottom portion of the prong to allow for the passage of an aerosolized treatment agent through the nasal prong. The activation member can be positioned on the nasal delivery device at a location that is spaced apart from the subject's oral cavity when the nasal prong is received into the nostril of the subject. The activation member can be configured to detect a desired exhalation state of the subject and upon detection of the desired exhalation state, the activation member activates the delivery of the aerosolized treatment agent.Type: GrantFiled: June 3, 2011Date of Patent: November 15, 2016Assignees: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CREARE LLCInventors: Mark J. Papania, James J. Barry, Mark C. Bagley, Eric M. Friets, Darin A. Knaus
-
Publication number: 20160058960Abstract: A nasal delivery device can include a nasal prong and an activation member. The nasal prong can comprises an opening at a top and bottom portion of the prong to allow for the passage of an aerosolized treatment agent through the nasal prong. The activation member can be positioned on the nasal delivery device at a location that is spaced apart from the subject's oral cavity when the nasal prong is received into the nostril of the subject. The activation member can be configured to detect a desired exhalation state of the subject and upon detection of the desired exhalation state, the activation member activates the delivery of the aerosolized treatment agent.Type: ApplicationFiled: April 3, 2014Publication date: March 3, 2016Applicants: The United State of America, as represented by The Secretary, Department of Health and Human Service, Creare IncorporatedInventors: Mark J. Papania, James J. Barry, Mark C. Bagley, James Norris, Darin A. Knaus, Eric M. Friets
-
Publication number: 20150136132Abstract: A nasal delivery device can include air-receiving section that has a first passageway therethrough to allow air to pass through the air-receiving section, a powder-reservoir receiving section sized to receive a powder reservoir, and a powder-delivery section that has a second passageway therethrough to allow aerosolized powder from the powder reservoir to pass through the powder-delivery section. The first passageway can have a first end and a second end, with the first end being further from the powder-reservoir receiving section and the second end being at or near the powder-reservoir receiving area. The second end of the air-receiving section can include a flattened region so that air exiting the air-receiving section has a generally flattened profile.Type: ApplicationFiled: June 24, 2013Publication date: May 21, 2015Inventors: Mark J. Papania, James J. Barry, Mark C. Bagley, Darin A. Knaus, Eric M. Friets, Edward Moynihan
-
Publication number: 20130072755Abstract: A nasal delivery device can include a nasal prong and an activation member. The nasal prong can comprises an opening at a top and bottom portion of the prong to allow for the passage of an aerosolized treatment agent through the nasal prong. The activation member can be positioned on the nasal delivery device at a location that is spaced apart from the subject's oral cavity when the nasal prong is received into the nostril of the subject. The activation member can be configured to detect a desired exhalation state of the subject and upon detection of the desired exhalation state, the activation member activates the delivery of the aerosolized treatment agent.Type: ApplicationFiled: June 3, 2011Publication date: March 21, 2013Inventors: Mark J. Papania, James J. Barry, Mark C. Bagley, Eric M. Friets, Darin A. Knaus